Global X S&P 500 Catholic Values ETF (CATH) Stock Price

83.1638 ▲ +1.6151 (+1.98%)
Open: 81.97 Vol: 17.77K Day's range: 81.97 - 83.22 Feb 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CATH Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 82.39▲ 82.39▲ 82.39▲ 82.71▲ 83.25▼
MA10 82.25▲ 82.32▲ 82.32▲ 83.10▲ 83.03▲
MA20 82.87▲ 82.80▲ 82.80▲ 83.06▲ 82.10▲
MA50 82.98▼ 82.88▲ 82.91▼ 82.87▲ 76.45▲
MA100 83.04▼ 82.95▼ 82.75▲ 82.06▲ 72.10▲
MA200 82.52▲ 82.17▲ 81.98▲ 78.35▲ 61.83▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.011▼ -0.007▼ -0.102▼ -0.255▼
RSI 51.735▲ 51.771▲ 51.946▲ 51.779▲ 59.980▲
STOCH 55.122     49.429     49.419     46.627     78.402    
WILL %R -36.453     -38.863     -39.720     -30.589     -15.572▲
CCI 49.541     30.608     30.143     -8.900     31.678    
Latest Filters Detected On CATH
RSI $CATH RSI(14) Crossed Above 50 Set Alert
MA $CATH Price Crossed Above MA(50) Set Alert
MA $CATH Price Crossed Above MA(26) Set Alert
MA $CATH Price Crossed Above MA(13) Set Alert
MA $CATH Price Crossed Above MA(7) Set Alert
CDL $CATH Marubozu Candlestick Pattern Detected Set Alert
Global X S&P 500 Catholic Values ETF News
Pulse Biosciences stock rises after positive cardiac catheter study data
Friday, February 06, 2026 08:11 AM
The ongoing feasibility study has treated a total of 165 patients across nine investigators in Europe. The company’s CEO, Paul LaViolette, described the results as "an important milestone" that ...
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
Thursday, February 05, 2026 02:00 PM
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking ...
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference
Thursday, February 05, 2026 05:08 AM
About LockeT Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and ...
CATH historical stock data
date open high low close volume
06/02/26 81.97 83.22 81.97 83.1638 17,775
05/02/26 81.82 82.14 81.42 81.5487 35,638
04/02/26 82.98 82.98 82.205 82.4112 21,251
03/02/26 83.69 83.69 82.1801 82.864 19,898
02/02/26 83.31 83.74 82.98 83.57 54,264
30/01/26 83.09 83.485 82.893 83.174 36,100
29/01/26 83.28 83.5387 82.455 83.5387 19,253
28/01/26 83.80 83.9499 83.55 83.7352 30,217
27/01/26 83.43 83.7509 83.43 83.64 31,232
26/01/26 82.99 83.4817 82.99 83.3248 23,023
Quote Details
52wk Low:58.39
52wk High:83.95
Vol:17.77K
Avg Vol(3m):441.2K
1Y Chng:+16.04%
1M Chng:-0.64%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00